Please login to the form below

Not currently logged in
Email:
Password:

meningitis

This page shows the latest meningitis news and features for those working in and with pharma, biotech and healthcare.

Declining childhood vaccination rates ring alarm bells in England

Declining childhood vaccination rates ring alarm bells in England

The figures also showed decreases in coverage of the 5-in-1 vaccine – which protects against diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus influenza type b (which can cause meningitis) –

Latest news

More from news
Approximately 14 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK. ... In a campaign first, Pfizer granted full creative licence to ten

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    One example is the Teddy Bears’ Picnic on the banks of the river Thames near Tower Bridge, which aimed to raise awareness of bacterial meningitis.

  • Pharma deals in June 2015 Pharma deals in June 2015

    When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in ... As a result GSK has sold two of its own

  • Pharma deals during July 2014 Pharma deals during July 2014

    The transaction includes two vaccines currently marketed outside the US and primarily in Europe: NeisVac-C, a vaccine against group C meningococcal meningitis (MenC), and FSME-IMMUN against tick-borne encephalitis

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. Also included in the meningitis “goodie

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • UK vs US: what makes a successful immunisation programme?

    The Meningitis B vaccine is unique to the UK and since we live in the UK that was easy to get.

  • Power to the People: Why consultation is key for improved patient outcomes

    Our roadmap. When it comes to developing a Roadmap to Defeat Meningitis, Meningitis Research Foundation is using the public consultation to gather vital views and generate new advocates that will help ... To learn more about Meningitis Research

  • HAVAS Just:: HAVAS Just::

    Abbvie. AstraZeneca. Caris Life Sciences. Lilly. Meningitis Trust. Mundipharma. Napp Pharmaceuticals.

  • Say Communications Say Communications

    Leadiant Biosciences. MDNA Life Sciences. Meningitis Research Foundation. MZP Tech. Natia Care. ... Meningitis Research Foundation has been working with Say Communications to help boost our public consultation on a Roadmap to Defeat Meningitis.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics